Par Drugs (India) Price History

PAR Stock   189.99  2.00  1.04%   
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 189.99, as last reported on the 7th of February, with the highest price reaching 193.90 and the lowest price hitting 189.20 during the day.
200 Day MA
239.2296
50 Day MA
214.678
Beta
0.153
 
Covid
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of -0.0942, which implies the firm had a -0.0942 % return per unit of risk over the last 3 months. Par Drugs And exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Par Drugs' Coefficient Of Variation of (910.59), variance of 27.58, and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide.
  
The current year's Total Stockholder Equity is expected to grow to about 1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.2 M. . Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0942

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPAR

Estimated Market Risk

 5.46
  actual daily
48
52% of assets are more volatile

Expected Return

 -0.51
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Par Drugs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding Par Drugs to a well-diversified portfolio.
Price Book
2.4414
Book Value
78.685
Enterprise Value
2.2 B
Enterprise Value Ebitda
7.7304
Price Sales
2.2639

Par Drugs Stock Price History Chart

There are several ways to analyze Par Stock price data. The simplest method is using a basic Par candlestick price chart, which shows Par Drugs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 2, 2024348.45
Lowest PriceJanuary 13, 2025182.7

Par Drugs February 7, 2025 Stock Price Synopsis

Various analyses of Par Drugs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Par Stock. It can be used to describe the percentage change in the price of Par Drugs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Par Stock.
Par Drugs Market Facilitation Index 0.0004 
Par Drugs Accumulation Distribution 285.13 
Par Drugs Price Action Indicator(2.56)
Par Drugs Price Daily Balance Of Power(0.43)
Par Drugs Price Rate Of Daily Change 0.99 

Par Drugs February 7, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Par Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Par Drugs intraday prices and daily technical indicators to check the level of noise trading in Par Stock and then apply it to test your longer-term investment strategies against Par.

Par Stock Price History Data

The price series of Par Drugs for the period between Sat, Nov 9, 2024 and Fri, Feb 7, 2025 has a statistical range of 165.75 with a coefficient of variation of 18.16. The price distribution for the period has arithmetic mean of 232.07. The median price for the last 90 days is 215.45. The company completed stock split (2:1) on 27th of April 2021. Par Drugs And had dividends distributed to its stock-holders on 2021-11-22.
OpenHighLowCloseVolume
02/06/2025 192.00  193.90  189.20  189.99  11,763 
02/05/2025 198.00  203.25  191.35  191.99  40,973 
02/04/2025 200.43  200.45  193.00  193.58  9,364 
02/03/2025 191.77  201.49  190.50  200.43  30,365 
01/31/2025 185.41  194.68  185.41  193.52  48,676 
01/30/2025 192.35  193.00  184.81  185.41  85,707 
01/29/2025 191.40  197.90  191.40  192.30  107,612 
01/28/2025 186.49  206.12  186.49  201.48  50,295 
01/27/2025 197.40  200.00  192.91  196.31  22,601 
01/24/2025 201.02  204.00  197.25  203.07  33,922 
01/23/2025 194.00  201.00  193.00  200.02  23,524 
01/22/2025 194.00  200.01  194.00  196.34  53,415 
01/21/2025 190.00  197.93  190.00  197.09  46,144 
01/20/2025 192.90  195.65  191.05  194.93  16,633 
01/17/2025 191.50  194.90  188.10  192.26  17,395 
01/16/2025 188.65  193.95  188.65  190.39  16,875 
01/15/2025 193.90  193.90  185.61  187.57  51,523 
01/14/2025 181.50  195.20  181.50  190.24  45,523 
01/13/2025 196.00  197.45  180.50  182.70  80,721 
01/10/2025 209.50  209.50  196.41  198.52  51,704 
01/09/2025 200.50  208.90  200.50  204.40  119,176 
01/08/2025 211.83  211.83  201.69  203.75  42,595 
01/07/2025 206.50  208.05  201.02  206.03  46,085 
01/06/2025 214.00  214.86  197.24  202.09  85,045 
01/03/2025 220.00  220.00  212.82  213.77  42,785 
01/02/2025 212.00  219.95  207.30  217.99  208,448 
12/31/2024 203.00  203.05  196.05  198.90  52,975 
12/30/2024 201.60  204.20  200.00  202.25  62,846 
12/27/2024 208.00  208.00  200.50  201.60  59,188 
12/26/2024 206.00  209.95  201.50  204.85  42,042 
12/24/2024 206.90  207.75  201.95  205.40  54,385 
12/23/2024 206.80  211.80  203.00  205.15  66,262 
12/20/2024 215.45  217.35  207.00  209.15  98,823 
12/19/2024 200.05  219.65  200.05  215.45  254,016 
12/18/2024 217.00  217.00  200.00  204.45  194,163 
12/17/2024 222.00  223.85  215.10  215.75  111,664 
12/16/2024 225.00  225.95  221.05  222.25  52,226 
12/13/2024 221.75  227.00  220.10  222.95  76,732 
12/12/2024 228.60  230.05  224.00  224.50  66,249 
12/11/2024 229.10  233.00  226.00  228.60  116,252 
12/10/2024 230.80  234.55  226.65  229.40  246,847 
12/09/2024 235.40  237.45  227.00  228.35  269,381 
12/06/2024 238.50  242.00  233.40  235.40  366,732 
12/05/2024 220.00  249.75  219.95  237.85  1,876,390 
12/04/2024 241.00  249.80  223.05  223.95  2,770,921 
12/03/2024 295.00  303.70  278.80  278.80  1,136,472 
12/02/2024 296.00  348.45  296.00  348.45  1,425,815 
11/29/2024 279.05  292.50  279.00  290.40  166,929 
11/28/2024 278.00  287.00  272.35  279.05  229,324 
11/27/2024 292.75  292.75  276.00  277.60  159,242 
11/26/2024 292.50  294.85  285.30  288.35  173,446 
11/25/2024 299.00  304.65  289.00  292.50  211,945 
11/22/2024 283.90  307.00  281.50  294.05  534,135 
11/21/2024 283.50  290.65  280.00  281.40  74,997 
11/20/2024 289.35  289.35  289.35  289.35  1.00 
11/19/2024 271.60  297.90  268.95  289.35  864,088 
11/18/2024 272.00  275.20  255.15  267.60  123,860 
11/14/2024 270.10  278.00  270.10  271.10  58,016 
11/13/2024 268.15  277.75  268.05  269.00  66,112 
11/12/2024 293.70  293.70  271.05  273.55  90,059 
11/11/2024 292.10  299.10  282.60  285.50  79,253 

About Par Drugs Stock history

Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.2 M11.2 M
Net Income Applicable To Common Shares106 M65.2 M

Par Drugs Quarterly Net Working Capital

337.1 Million

Par Drugs Stock Technical Analysis

Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Par Drugs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Par Drugs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Par Drugs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Par Stock analysis

When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities